A high scale SARS-CoV-2 profiling by its whole-genome sequencing using Oxford Nanopore Technology in Kazakhstan

被引:2
|
作者
Kairov, Ulykbek [1 ]
Amanzhanova, Amina [1 ]
Karabayev, Daniyar [1 ]
Rakhimova, Saule [1 ]
Aitkulova, Akbota [2 ]
Samatkyzy, Diana [1 ]
Kalendar, Ruslan [1 ]
Kozhamkulov, Ulan [1 ]
Molkenov, Askhat [1 ]
Gabdulkayum, Aidana [1 ]
Sarbassov, Dos [1 ,2 ]
Akilzhanova, Ainur [1 ]
机构
[1] Nazarbayev Univ, Ctr Life Sci, Natl Lab Astana, Nur Sultan, Kazakhstan
[2] Nazarbayev Univ, Sch Sci & Humanities, Nur Sultan, Kazakhstan
关键词
Kazakhstan; third-generation sequencing; Oxford Nanopore; SARS-CoV-2 genome sequencing; COVID-19;
D O I
10.3389/fgene.2022.906318
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Severe acute respiratory syndrome (SARS-CoV-2) is responsible for the worldwide pandemic, COVID-19. The original viral whole-genome was sequenced by a high-throughput sequencing approach from the samples obtained from Wuhan, China. Real-time gene sequencing is the main parameter to manage viral outbreaks because it expands our understanding of virus proliferation, spread, and evolution. Whole-genome sequencing is critical for SARS-CoV-2 variant surveillance, the development of new vaccines and boosters, and the representation of epidemiological situations in the country. A significant increase in the number of COVID-19 cases confirmed in August 2021 in Kazakhstan facilitated a need to establish an effective and proficient system for further study of SARS-CoV-2 genetic variants and the development of future Kazakhstan's genomic surveillance program. The SARS-CoV-2 whole-genome was sequenced according to SARS-CoV-2 ARTIC protocol (EXP-MRT001) by Oxford Nanopore Technologies at the National Laboratory Astana, Kazakhstan to track viral variants circulating in the country. The 500 samples kindly provided by the Republican Diagnostic Center (UMC-NU) and private laboratory KDL "Olymp " were collected from individuals in Nur-Sultan city diagnosed with COVID-19 from August 2021 to May 2022 using real-time reverse transcription-quantitative polymerase chain reaction (RT-qPCR). All samples had a cycle threshold (Ct) value below 20 with an average Ct value of 17.03. The overall average value of sequencing depth coverage for samples is 244X. 341 whole-genome sequences that passed quality control were deposited in the Global initiative on sharing all influenza data (GISAID). The BA.1.1 (n = 189), BA.1 (n = 15), BA.2 (n = 3), BA.1.15 (n = 1), BA.1.17.2 (n = 1) omicron lineages, AY.122 (n = 119), B.1.617.2 (n = 8), AY.111 (n = 2), AY.126 (n = 1), AY.4 (n = 1) delta lineages, one sample B.1.1.7 (n = 1) belongs to alpha lineage, and one sample B.1.637 (n = 1) belongs to small sublineage were detected in this study. This is the first study of SARS-CoV-2 whole-genome sequencing by the ONT approach in Kazakhstan, which can be expanded for the investigation of other emerging viral or bacterial infections on the country level.
引用
收藏
页数:8
相关论文
共 50 条
  • [41] Whole-genome sequencing of SARS-CoV-2 from the initial cases of domestic cat infections in Canada
    Sultana, Asma
    Bienzle, Dorothee
    Weese, Scott
    Pickering, Brad
    Kruczkiewicz, Peter
    Smith, Greg
    Pinette, Mathieu
    Lung, Oliver
    MICROBIOLOGY RESOURCE ANNOUNCEMENTS, 2024, 13 (04):
  • [42] Whole-Genome Sequencing Reveals Major Shifts in SARS-CoV-2 Genotypes in the Greater NYC Region
    Streva, V.
    Duong, S.
    Juretschko, S.
    Lemon, J.
    Streva, V.
    Zhang, F.
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2022, 24 (10): : S58 - S58
  • [43] Whole-genome sequencing of SARS-CoV-2 reveals the detection of G614 variant in Pakistan
    Umair, Massab
    Ikram, Aamer
    Salman, Muhammad
    Khurshid, Adnan
    Alam, Masroor
    Badar, Nazish
    Suleman, Rana
    Tahir, Faheem
    Sharif, Salmaan
    Montgomery, Joel
    Whitmer, Shannon
    Klena, John
    PLOS ONE, 2021, 16 (03):
  • [44] Whole-genome sequencing to investigate transmission of SARS-CoV-2 in the acute healthcare setting: a systematic review
    Hare, D.
    Dembicka, K. M.
    Brennan, C.
    Sutton-Fitzpatrick, U.
    Stapleton, P. J.
    De Gascun, C. F.
    Dunne, C. P.
    JOURNAL OF HOSPITAL INFECTION, 2023, 140 : 139 - 155
  • [45] Repeated transmission of SARS-CoV-2 in an overcrowded Irish emergency department elucidated by whole-genome sequencing
    Hare, D.
    Meaney, C.
    Powell, J.
    Slevin, B.
    O' Brien, B.
    Power, L.
    O' Connell, N. H.
    De Gascun, C. F.
    Dunne, C. P.
    Stapleton, P. J.
    JOURNAL OF HOSPITAL INFECTION, 2022, 126 : 1 - 9
  • [46] Symptomatic SARS-CoV-2 Reinfection in a Healthy Healthcare Worker in Italy Confirmed by Whole-Genome Sequencing
    Loconsole, Daniela
    Sallustio, Anna
    Accogli, Marisa
    Centrone, Francesca
    Casulli, Daniele
    Madaro, Antonino
    Tedeschi, Ersilia
    Parisi, Antonio
    Chironna, Maria
    VIRUSES-BASEL, 2021, 13 (05):
  • [47] Identification of Genomic Variants of SARS-CoV-2 Using Nanopore Sequencing
    Capraru, Ionut Dragos
    Romanescu, Mirabela
    Anghel, Flavia Medana
    Oancea, Cristian
    Marian, Catalin
    Sirbu, Ioan Ovidiu
    Chis, Aimee Rodica
    Ciordas, Paula Diana
    MEDICINA-LITHUANIA, 2022, 58 (12):
  • [48] An Evaluation of Avian Influenza Virus Whole-Genome Sequencing Approaches Using Nanopore Technology
    Ip, Hon S.
    Uhm, Sarah
    Killian, Mary Lea
    Torchetti, Mia K.
    MICROORGANISMS, 2023, 11 (02)
  • [49] NASCarD (Nanopore Adaptive Sampling with Carrier DNA): A Rapid, PCR-Free Method for SARS-CoV-2 Whole-Genome Sequencing in Clinical Samples
    Terrazos Miani, Miguel A.
    Borcard, Loic
    Gempeler, Sonja
    Baumann, Christian
    Bittel, Pascal
    Leib, Stephen L.
    Neuenschwander, Stefan
    Ramette, Alban
    PATHOGENS, 2024, 13 (01):
  • [50] Optimised protocol for monitoring SARS-CoV-2 in wastewater using reverse complement PCR-based whole-genome sequencing
    Child, Harry T.
    O'Neill, Paul A.
    Moore, Karen
    Rowe, William
    Denise, Hubert
    Bass, David
    Wade, Matthew J.
    Loose, Matt
    Paterson, Steve
    van Aerle, Ronny
    Jeffries, Aaron R.
    PLOS ONE, 2023, 18 (04):